Liver Fibrosis Reduced with HIV-Hep C Co-Infection
Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients
by Michael Carter
July 20, 2011
Treatment with maraviroc is associated with the regression of liver fibrosis in HIV-positive patients co-infected with hepatitis C, a small randomised study presented to the Sixth International AIDS Society conference in Rome shows.
Investigators from the University of Brescia in Italy believe that the beneficial impact of maraviroc (Celsentri) was due to its inhibition of CCR5.
Continue reading this entire article:
http://www.aidsmap.com/page/1882378/